Related Experiment Video

Updated: Jul 9, 2026

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors
16:49

Two Methods of Heterokaryon Formation to Discover HCV Restriction Factors

Published on: July 16, 2012

[Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count]

Małgorzata Inglot1, Aleksandra Szymczak, Andrzej Gładysz

  • 1Katedra i Klinika Chorób Zakaźnych, Chorób Watroby i Nabytych Niedoborów Odpornościowych AM we Wrocławiu. minglot@k.pl

Przeglad Epidemiologiczny
|December 12, 2007
PubMed

Insights

Hepatitis C virus (HCV) infection progresses slowly in individuals with human immunodeficiency virus (HIV) and high CD4+ counts. Favorable factors for treatment include a high prevalence of HCV genotype 3 and mild liver fibrosis.

Area of Science:

  • Hepatology and Virology
  • Infectious Diseases
  • Immunology

Context:

  • Human immunodeficiency virus (HIV) and Hepatitis C virus (HCV) coinfection presents unique challenges in patient management.
  • Antiretroviral therapy (ART) plays a crucial role in managing HIV, potentially influencing HCV progression.
  • Understanding the interplay between HIV, HCV, and host immune status is vital for predicting disease trajectory.

Purpose:

  • To analyze the characteristics of HCV infection in patients coinfected with HIV.
  • To evaluate the impact of antiretroviral therapy on disease progression.
  • To identify prognostic factors for liver fibrosis progression in this coinfected population.

Summary:

  • This study analyzed 37 HIV/HCV coinfected patients, assessing viral loads, genotypes, immune markers (CD4+ counts), and liver histology.
  • Effective antiretroviral therapy was associated with higher CD4+ counts (>350 cells/microl).
  • HCV genotype 3a was prevalent (59%), and mild liver fibrosis (stage <2) was observed in the majority (62%), with slower progression noted in patients with higher CD4+ counts.

Impact:

  • Identifies slow liver fibrosis progression in HIV/HCV coinfected patients with high CD4+ counts.
  • Highlights high prevalence of HCV genotype 3 and mild fibrosis as positive prognostic indicators for HCV treatment efficacy in HIV-positive individuals.
  • Informs clinical management strategies for coinfected patients, emphasizing the importance of immune status and HCV genotype.
Abstract

More Related Videos

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...